The global anti-malarial drug market is expected to grow from USD 816.09 million in 2019 to USD 1,040 million by 2027, at a CAGR of 3.2% during the forecast period 2020-2027.
Anti-malarial drugs or medications are a class of anti-parasitic chemical agents that employed to prevent or treat malaria. Malaria is a curable, but also life-threatening disease caused by parasites transmitted to humans via the bite of the female Anopheles mosquito. These parasites, known as Plasmodiums, reside in the liver cells where they develop and multiply. There are various types of medications available on the market for the treatment of malaria such as chloroquine, mefloquine, pyrimethamine and others.
This study delivers a comprehensive analysis of distribution channels, drug classes and regions. The research includes growth drivers as well as challenges prevalent in the global anti-malarial drug market along with the impact they will have on the overall demand during the forecasted period. Additionally, the study also includes various opportunities & threats that are present in the anti-malarial drug market. Based on the distribution channel, the global anti-malarial drug market has been divided into e-commerce, retail pharmacy, hospital pharmacy and others. The hospital pharmacy segment accounted for the majority market share globally due to rising number of medication prescriptions and hospitals globally. The e-commerce segment is projected to display the highest growth rate in the forecast period due to an increase in internet users worldwide. The drug class segment includes proguanil, quinine, mefloquine, pyrimethamine, chloroquine, and others. The others segment is expected to dominate the market with the highest CAGR within the forecast period as well as accounting for the largest share of the market. The primary factor behind this is that the malarial parasites have already developed a resistance towards most common drugs in the market.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. With a better understanding of the applications of anti-malarial drugs, the Asia-Pacific region stands as a promising market for anti-malarial drugs and is expected to grow at the highest CAGR during the forecast period. However, the LAMEA region represented the largest market share of anti-malarial medicines, and this trend is projected to continue.
Some of the notable players in the anti-malarial drug market are Pfizer Inc., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Ipca Laboratories Ltd., Alvizia Healthcare Pvt. Ltd., Merck & Co., Inc, and F. Hoffmann-La Roche Ltd., among others. The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global anti-malarial drug industry.
This study predicts revenue growth at global, national, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Anti-Malarial Drug Market Analysis And Forecast, By Distribution Channel
Global Anti-Malarial Drug Market Analysis And Forecast, By Drug Class
Global Anti-Malarial Drug Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Distribution Channel
4.3.2. Market Attractiveness Analysis By Drug Class
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Opportunities
5.5. Challenges
6. Global Anti-malarial Drug Market Analysis and Forecast, By Distribution Channel
6.1. Segment Overview
6.2. E-commerce
6.3. Retail Pharmacy
6.4. Hospital Pharmacy
6.5. Others
7. Global Anti-malarial Drug Market Analysis and Forecast, By Drug Class
7.1. Segment Overview
7.2. Proguanil
7.3. Quinine
7.4. Mefloquine
7.5. Pyrimethamine
7.6. Chloroquine
7.7. Others
8. Global Anti-malarial Drug Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Anti-malarial Drug Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Anti-malarial Drug Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Pfizer Inc
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Sun Pharmaceutical Industries Ltd
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. GlaxoSmithKline Plc
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Ipca Laboratories Ltd
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Alvizia Healthcare Pvt. Ltd
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Merck & Co., Inc
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. F. Hoffmann-La Roche Ltd
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
List of Table
1. Global Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
2. Global E-commerce Market, By Region, 2017–2027(USD Million)
3. Global Retail Pharmacy, By Region, 2017–2027(USD Million)
4. Global Others Market, By Region, 2017–2027(USD Million)
5. Global Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
6. Global Proguanil Anti-malarial Drug Market, By Region, 2017–2027(USD Million)
7. Global Quinine Anti-Malarial Drug Market, By Region, 2017–2027(USD Million)
8. Global Mefloquine Anti-Malarial Drug Market, By Region, 2017–2027(USD Million)
9. Global Pyrimethamine Anti-Malarial Drug Market, By Region, 2017–2027(USD Million)
10. Global Chloroquine Anti-Malarial Drug Market, By Region, 2017–2027(USD Million)
11. Global Others Anti-Malarial Drug Market, By Region, 2017–2027(USD Million)
12. Global Anti-malarial Drug Market, By North America, 2017–2027(USD Million)
13. North America Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
14. North America Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
15. U.S. Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
16. U.S. Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
17. Canada Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
18. Canada Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
19. Mexico Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
20. Mexico Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
21. Europe Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
22. Europe Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
23. Germany Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
24. Germany Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
25. France Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
26. France Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
27. U.K. Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
28. U.K. Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
29. Italy Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
30. Italy Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
31. Spain Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
32. Spain Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
33. Asia Pacific Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
34. Asia Pacific Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
35. Japan Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
36. Japan Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
37. China Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
38. China Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
39. India Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
40. India Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
41. South America Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
42. South America Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
43. Brazil Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
44. Brazil Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
45. Middle East and Africa Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
46. Middle East and Africa Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
47. UAE Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
48. UAE Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
49. South Africa Anti-malarial Drug Market, By Distribution Channel, 2017–2027(USD Million)
50. South Africa Anti-malarial Drug Market, By Drug Class, 2017–2027(USD Million)
List of Figures
1. Global Anti-malarial Drug Market Segmentation
2. Anti-malarial Drug Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Anti-malarial Drug Market Attractiveness Analysis By Distribution Channel
9. Global Anti-malarial Drug Market Attractiveness Analysis By Drug Class
10. Global Anti-malarial Drug Market Attractiveness Analysis By Region
11. Global Anti-malarial Drug Market: Dynamics
12. Global Anti-malarial Drug Market Share By Distribution Channel (2019 & 2027)
13. Global Anti-malarial Drug Market Share By Drug Class (2019 & 2027)
14. Global Anti-malarial Drug Market Share by Regions (2019 & 2027)
15. Global Anti-malarial Drug Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.